Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG

Jacques Wils, Tarek Sahmoud, Alberto Sobrero, Harry Bleiberg, Sam Ahmedzai, Jane Blazeby, Geert Blijham, Thierry Conroy, David Cunningham, Desmond Curran, Eduardo Díaz-Rubio, Michel Ducreux, Jeff Evans, Bengt Glimelius, Gillian Hutchinson, David Kerr, Gwendoline Kiebert, Hennig Köhne, Roberto Labianca, Rina LangendijkDonato Nitti, Bernard Nordlinger, Philippe Rougier, Werner Scheithauer, Hans Joachim Schmoll, Eric Van Cutsem, Theo Wagener, Jochen Wilke, Ann Marinus, Patrick Therasse

Research output: Contribution to journalArticle

Abstract

During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as 'patient benefit'. For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.

Original languageEnglish
Pages (from-to)335-347
Number of pages13
JournalTumori
Volume84
Issue number3
Publication statusPublished - May 1998

Fingerprint

Gastrointestinal Neoplasms
Colorectal Neoplasms
Organizations
Education
Research
Therapeutics
Quality of Life
Drug Therapy
Survival
Pharmaceutical Preparations

Keywords

  • Advanced colorectal cancer
  • Endpoints of medical treatment

ASJC Scopus subject areas

  • Cancer Research

Cite this

Wils, J., Sahmoud, T., Sobrero, A., Bleiberg, H., Ahmedzai, S., Blazeby, J., ... Therasse, P. (1998). Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. Tumori, 84(3), 335-347.

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. / Wils, Jacques; Sahmoud, Tarek; Sobrero, Alberto; Bleiberg, Harry; Ahmedzai, Sam; Blazeby, Jane; Blijham, Geert; Conroy, Thierry; Cunningham, David; Curran, Desmond; Díaz-Rubio, Eduardo; Ducreux, Michel; Evans, Jeff; Glimelius, Bengt; Hutchinson, Gillian; Kerr, David; Kiebert, Gwendoline; Köhne, Hennig; Labianca, Roberto; Langendijk, Rina; Nitti, Donato; Nordlinger, Bernard; Rougier, Philippe; Scheithauer, Werner; Schmoll, Hans Joachim; Van Cutsem, Eric; Wagener, Theo; Wilke, Jochen; Marinus, Ann; Therasse, Patrick.

In: Tumori, Vol. 84, No. 3, 05.1998, p. 335-347.

Research output: Contribution to journalArticle

Wils, J, Sahmoud, T, Sobrero, A, Bleiberg, H, Ahmedzai, S, Blazeby, J, Blijham, G, Conroy, T, Cunningham, D, Curran, D, Díaz-Rubio, E, Ducreux, M, Evans, J, Glimelius, B, Hutchinson, G, Kerr, D, Kiebert, G, Köhne, H, Labianca, R, Langendijk, R, Nitti, D, Nordlinger, B, Rougier, P, Scheithauer, W, Schmoll, HJ, Van Cutsem, E, Wagener, T, Wilke, J, Marinus, A & Therasse, P 1998, 'Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG', Tumori, vol. 84, no. 3, pp. 335-347.
Wils, Jacques ; Sahmoud, Tarek ; Sobrero, Alberto ; Bleiberg, Harry ; Ahmedzai, Sam ; Blazeby, Jane ; Blijham, Geert ; Conroy, Thierry ; Cunningham, David ; Curran, Desmond ; Díaz-Rubio, Eduardo ; Ducreux, Michel ; Evans, Jeff ; Glimelius, Bengt ; Hutchinson, Gillian ; Kerr, David ; Kiebert, Gwendoline ; Köhne, Hennig ; Labianca, Roberto ; Langendijk, Rina ; Nitti, Donato ; Nordlinger, Bernard ; Rougier, Philippe ; Scheithauer, Werner ; Schmoll, Hans Joachim ; Van Cutsem, Eric ; Wagener, Theo ; Wilke, Jochen ; Marinus, Ann ; Therasse, Patrick. / Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. In: Tumori. 1998 ; Vol. 84, No. 3. pp. 335-347.
@article{0969e7a6ce3a4af7a0ec85969e5ae57f,
title = "Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG",
abstract = "During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as 'patient benefit'. For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.",
keywords = "Advanced colorectal cancer, Endpoints of medical treatment",
author = "Jacques Wils and Tarek Sahmoud and Alberto Sobrero and Harry Bleiberg and Sam Ahmedzai and Jane Blazeby and Geert Blijham and Thierry Conroy and David Cunningham and Desmond Curran and Eduardo D{\'i}az-Rubio and Michel Ducreux and Jeff Evans and Bengt Glimelius and Gillian Hutchinson and David Kerr and Gwendoline Kiebert and Hennig K{\"o}hne and Roberto Labianca and Rina Langendijk and Donato Nitti and Bernard Nordlinger and Philippe Rougier and Werner Scheithauer and Schmoll, {Hans Joachim} and {Van Cutsem}, Eric and Theo Wagener and Jochen Wilke and Ann Marinus and Patrick Therasse",
year = "1998",
month = "5",
language = "English",
volume = "84",
pages = "335--347",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG

AU - Wils, Jacques

AU - Sahmoud, Tarek

AU - Sobrero, Alberto

AU - Bleiberg, Harry

AU - Ahmedzai, Sam

AU - Blazeby, Jane

AU - Blijham, Geert

AU - Conroy, Thierry

AU - Cunningham, David

AU - Curran, Desmond

AU - Díaz-Rubio, Eduardo

AU - Ducreux, Michel

AU - Evans, Jeff

AU - Glimelius, Bengt

AU - Hutchinson, Gillian

AU - Kerr, David

AU - Kiebert, Gwendoline

AU - Köhne, Hennig

AU - Labianca, Roberto

AU - Langendijk, Rina

AU - Nitti, Donato

AU - Nordlinger, Bernard

AU - Rougier, Philippe

AU - Scheithauer, Werner

AU - Schmoll, Hans Joachim

AU - Van Cutsem, Eric

AU - Wagener, Theo

AU - Wilke, Jochen

AU - Marinus, Ann

AU - Therasse, Patrick

PY - 1998/5

Y1 - 1998/5

N2 - During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as 'patient benefit'. For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.

AB - During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as 'patient benefit'. For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.

KW - Advanced colorectal cancer

KW - Endpoints of medical treatment

UR - http://www.scopus.com/inward/record.url?scp=0031837358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031837358&partnerID=8YFLogxK

M3 - Article

C2 - 9678614

AN - SCOPUS:0031837358

VL - 84

SP - 335

EP - 347

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -